http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56154416-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9a4bdaaa125c435f13a802ac518c9ea
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1980-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b8175d11d0975bbd7e699a93df56ff2
publicationDate 1981-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S56154416-A
titleOfInvention Antipyretic analgesic composition
abstract PURPOSE: An effective antipyretic analgesic that is composed of ibuprofen, an antipyretic analgesic of aniline derivative, caffein and thiamine hydrochloride. n CONSTITUTION: The objective antipyretic analgesic is composed of ibuprofen, an antipyretic analgesic of aniline derivative such as busetin, a caffein and thiamine hydrochloride. In the composition, the caffein and thiamine hydrochloride are 2W 30wt% and 0.5W5wt% respectively on the basis of the combined amount of the two former compounds. The addition of caffein and thiamine hydrochloride raise the pain threshold according to the pressure stimulation method and prolongs the duration time measured by the Randall-Selitto method in spite of the same level in the antipyretic activity and the acute toxicity. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2530468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-9500645-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NL-9500644-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2530469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0560810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59501459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5726180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5973520-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05148139-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-389999-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59501413-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0124131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62292718-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5629316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-389997-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5409709-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62500961-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0987174-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0105635-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0551568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-389051-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-389998-B
priorityDate 1980-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5423132-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448540569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293

Total number of triples: 49.